Ignite Creation Date:
2025-12-18 @ 9:53 AM
Ignite Modification Date:
2025-12-23 @ 10:50 PM
Study NCT ID:
NCT05372614
Status:
None
Last Update Posted:
2025-12-09 00:00:00
First Post:
2022-05-12 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
Sponsor:
None
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-05
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-05-12 00:00:00
First Submit QC Date:
None
Study First Post Date:
2022-05-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-06 00:00:00
Last Update Post Date:
2025-12-09 00:00:00
Last Update Post Date Type:
ESTIMATED